Our prognostic signature comprising 151 probe sets differentially expressed between the two clusters included mostly genes that were related to ECM structure and functions and immunological response; two of these—DSPG3 and LOX—were validated by quantitative PCR in the initial and independent sets of ovarian cancer samples and were associated with OS and DFS. This evidence concerns the gene EPYC and ovarian cancer.